PDL BioPharma, Inc. (PDLI) Ex-Dividend Date Scheduled for December 05, 2012


Shutterstock photo

PDL BioPharma, Inc. ( PDLI ) has announced an ex-dividend date of December 05, 2012 and a cash dividend payment of $0.15 per share scheduled for December 14, 2012. Shareholders who purchased PDLI stock prior to the ex-dividend date are eligible for the cash dividend payment. This marks the 8th quarter that PDLI has paid the same dividend. At the current stock price of $7.9, the dividend yield is 7.59%.

The previous trading day's last sale of PDLI was $7.9, representing a -6.29% decrease from the 52 week high of $8.43 and a 37.15% increase over the 52 week low of $5.76.

PDLI is a part of the Health Care sector, which includes companies such as Amgen Inc. ( AMGN ) and Gilead Sciences, Inc. ( GILD ). PDLI's current earnings per share, an indicator of a company's profitability, is $1.37. Zacks Investment Research reports PDLI's forecasted earnings growth in 2012 as 20.51%, compared to an industry average of 8.5%.

For more information on the declaration, record and payment dates, visit the PDLI Dividend History page.

Interested in gaining exposure to PDLI through an Exchange Traded Fund [ETF]?
The following ETF(s) have PDLI as a top-10 holding:

  • WisdomTree SmallCap Earnings Fund ( EES ).

The top-performing ETF of this group is EES with an increase of 2.11% over the last 100 days. It also has the highest percent weighting of PDLI at 0.61%.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

This article appears in: News Headlines Stocks
Referenced Stocks: AMGN , EES , GILD , PDLI

More from NASDAQ.com News


NASDAQ.com News

NASDAQ.com News

Follow on:

Find a Credit Card

Select a credit card product by:
Select an offer:
Data Provided by BankRate.com